These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 19090546)
1. Pseudohypopyon: Extramedullary relapse of acute myelogenous leukemia with poor prognosis. Petersen WC; Schlis KD; Braverman RS; Carlson I; Liang X; Wang M Pediatr Blood Cancer; 2009 Jul; 52(7):885-7. PubMed ID: 19090546 [TBL] [Abstract][Full Text] [Related]
2. [Factors related to prognosis and relapse in acute myelomonocytic and monocytic leukemias (M4 and M5)]. Koyama A; Shirakawa C; Masaki H; Horiuchi F; Hamazaki H; Fujimoto T; Irimajiri K; Horiuchi A Rinsho Ketsueki; 1990 Nov; 31(11):1787-93. PubMed ID: 2287062 [TBL] [Abstract][Full Text] [Related]
3. Complex karyotypic abnormalities in a case of acute myeloid leukaemia--M4Eo. Leong CF; Azma RZ; Cheong SK; Salwati S; Sharifah NA Malays J Pathol; 2005 Jun; 27(1):45-50. PubMed ID: 16676693 [TBL] [Abstract][Full Text] [Related]
4. Leukemic relapse presenting as acute unilateral hypopyon in acute lymphocytic leukemia. Decker EB; Burnstine RA Ann Ophthalmol; 1993 Sep; 25(9):346-9. PubMed ID: 8297072 [TBL] [Abstract][Full Text] [Related]
5. Pseudo-hypopyon as the presenting feature of recurrent B-cell lymphoma. Papaliodis GN; Montezuma SR Ocul Immunol Inflamm; 2008; 16(3):121-2. PubMed ID: 18569803 [TBL] [Abstract][Full Text] [Related]
6. [Leukemia and pregnancy. Review apropos of a clinical case]. Perucca E; Dezerega V; González R; Rodríguez A; Aparicio R; Lois V Rev Chil Obstet Ginecol; 1995; 60(2):118-23; discussion 123-4. PubMed ID: 8559987 [TBL] [Abstract][Full Text] [Related]
7. Acute unilateral leukemic hypopyon in an adult with relapsing acute lymphoblastic leukemia. Yi DH; Rashid S; Cibas ES; Arrigg PG; Dana MR Am J Ophthalmol; 2005 Apr; 139(4):719-21. PubMed ID: 15808176 [TBL] [Abstract][Full Text] [Related]
8. [Ocular infiltration in the anterior chamber in a female infant with acute non-lymphoblastic leukemia]. Garrido Colino C; Mateos González M; Torres Valdivieso M; López Pérez J; Melero Moreno C; Vivanco Martínez J An Esp Pediatr; 2001 Jul; 55(1):69-72. PubMed ID: 11412473 [TBL] [Abstract][Full Text] [Related]
9. Acute pericarditis and pleural effusion complicating cytarabine chemotherapy. Gähler A; Hitz F; Hess U; Cerny T Onkologie; 2003 Aug; 26(4):348-50. PubMed ID: 12972701 [TBL] [Abstract][Full Text] [Related]
10. Successful combination therapy with infusion of allogenetic bone marrow mesenchymal stem cells and CAG regimen in hypoplastic relapsed acute myelogenous leukemia. Lu H; Lu SF; Shen WY; Hong M; Zhang JF; Wang LX; Yang H; Li JY Leuk Res; 2008 Nov; 32(11):1776-9. PubMed ID: 18501425 [No Abstract] [Full Text] [Related]
11. Three-day standard dose cytarabine could induce an M4Eo patient into complete remission. Higuchi T; Saito F; Mori H; Omine M Acta Haematol; 1997; 97(3):189-90. PubMed ID: 9066717 [No Abstract] [Full Text] [Related]
12. [The cytopathological features of the pseudohypopyon in a patient with acute monoblastic leukemia]. Ohshima K; Konishi H; Matsuo N; Hayashi K; Akazai A; Oda M; Seino Y Nippon Ganka Gakkai Zasshi; 1992 Apr; 96(4):536-40. PubMed ID: 1621597 [TBL] [Abstract][Full Text] [Related]
13. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group. Tsukimoto I; Tawa A; Horibe K; Tabuchi K; Kigasawa H; Tsuchida M; Yabe H; Nakayama H; Kudo K; Kobayashi R; Hamamoto K; Imaizumi M; Morimoto A; Tsuchiya S; Hanada R J Clin Oncol; 2009 Aug; 27(24):4007-13. PubMed ID: 19620491 [TBL] [Abstract][Full Text] [Related]
14. Neuroophthalmological side effects following intrathecal administration of liposomal cytarabine for central nervous system prophylaxis in three adolescents with acute myeloid leukaemia. Sommer C; Lackner H; Benesch M; Sovinz P; Schwinger W; Moser A; Bergloeff J; Gruber A; Urban C Ann Hematol; 2008 Nov; 87(11):887-90. PubMed ID: 18575860 [TBL] [Abstract][Full Text] [Related]
15. Relapsing acute myeloid leukemia manifesting as hypopyon uveitis. Ayliffe W; Foster CS; Marcoux P; Upton M; Finkelstein M; Kuperwaser M; Legmann A Am J Ophthalmol; 1995 Mar; 119(3):361-4. PubMed ID: 7872398 [TBL] [Abstract][Full Text] [Related]
17. Relapse of aggressive myeloma after complete remission in secondary acute leukemia: coincidence or consequence? Bairey OS; Sandbank Y; Shaklai M Leuk Lymphoma; 1993 Dec; 12(1-2):147-51. PubMed ID: 8161931 [TBL] [Abstract][Full Text] [Related]
18. When the eye gives it all: diagnosis of relapsing acute myeloblastic leukemia with anterior chamber tap of a chronic hypopyon. Touitou V; Bodaghi B; Thepot S; Chapiro E; Nguyen-Khac F; Charlotte F; LeHoang P; Maloum K Am J Hematol; 2014 Aug; 89(8):858-9. PubMed ID: 25165787 [No Abstract] [Full Text] [Related]
19. Leukemic hypopyon in acute myelogenous leukemia. Matano S; Ohta T; Nakamura S; Kanno M; Sugimoto T Ann Hematol; 2000 Aug; 79(8):455-8. PubMed ID: 10985367 [TBL] [Abstract][Full Text] [Related]
20. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway. Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]